Advertisement

Topics

Sanofi's Generics Business To Be Sold To Private Equity Firm, Advent

07:12 EDT 17 Apr 2018 | SCRIP

Sanofi will have €1.9bn to add to its war-chest when it concludes the sale of its European generics business.

      

Related Stories

 

Original Article: Sanofi's Generics Business To Be Sold To Private Equity Firm, Advent

NEXT ARTICLE

More From BioPortfolio on "Sanofi's Generics Business To Be Sold To Private Equity Firm, Advent"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...